Cite

HARVARD Citation

    Bastin, J. et al. (2019). Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies. Acta clinica belgica. 74 (3), pp. 169-179. [Online]. 
  
Back to record